As an anti-angiogenic agent, PCN-Len NPs targeted tyrosine kinases in vascular endothelial cells, leading to the downregulation of VEGF-A and Ang-2 expression, disrupting tumor angiogenesis subsequently decreasing the microvessel density [124,126,127,128]. The gene discussed is VEGFA; the disease is neoplasm.